Noga Givon-Lavi spends much of her time researching Streptococcus pneumoniae, Immunology, Serotype, Pneumococcal conjugate vaccine and Pneumococcal infections. Her Streptococcus pneumoniae research incorporates elements of Streptococcaceae, Internal medicine and Vaccination. The various areas that Noga Givon-Lavi examines in her Immunology study include Pneumococcal vaccine and Lower respiratory tract infection.
Her Serotype research is multidisciplinary, relying on both Prospective cohort study, El Niño and Disease. The Pneumococcal conjugate vaccine study combines topics in areas such as Incidence and Pediatrics. Within one scientific family, she focuses on topics pertaining to Antibiotic resistance under Pneumococcal infections, and may sometimes address concerns connected to Antimicrobial.
Her main research concerns Streptococcus pneumoniae, Serotype, Pneumococcal conjugate vaccine, Immunology and Pediatrics. In general Streptococcus pneumoniae, her work in Pneumococcal infections is often linked to Carriage linking many areas of study. Her research on Serotype also deals with topics like
Noga Givon-Lavi has researched Pneumococcal conjugate vaccine in several fields, including Odds ratio, Antibiotic resistance and Conjugate vaccine. Her work in the fields of Immunology, such as Antibody, Immunogenicity and Pathogenesis, overlaps with other areas such as Conjugate. Her Pediatrics research integrates issues from Epidemiology, Incidence, Prospective cohort study and Rotavirus.
The scientist’s investigation covers issues in Pneumococcal conjugate vaccine, Serotype, Internal medicine, Carriage and Streptococcus pneumoniae. Her Pneumococcal conjugate vaccine research is multidisciplinary, incorporating perspectives in Respiratory tract infections, Colonization, Virology, Antibiotic resistance and Pediatrics. In her work, Pneumococcal disease, Demographic profile and Comorbidity is strongly intertwined with Disease, which is a subfield of Serotype.
The study incorporates disciplines such as Gastroenterology and Otitis in addition to Internal medicine. Noga Givon-Lavi integrates Carriage with Vaccination in her study. Much of her study explores Streptococcus pneumoniae relationship to Immunology.
Her primary scientific interests are in Pneumococcal conjugate vaccine, Serotype, Internal medicine, Carriage and Colonization. Her Pneumococcal conjugate vaccine study incorporates themes from Antibiotic resistance and Pneumonia. As a part of the same scientific family, Noga Givon-Lavi mostly works in the field of Serotype, focusing on Disease and, on occasion, Virology, Pneumococcal disease, Demographic profile and Comorbidity.
The concepts of her Internal medicine study are interwoven with issues in Gastroenterology, Conjugated vaccines and Haemophilus influenzae, Tympanocentesis. Other disciplines of study, such as Vaccination and Streptococcus pneumoniae, are mixed together with her Carriage studies. Her Colonization study combines topics in areas such as Transmission, Immunity and Pneumococcal infections.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers.
Ron Dagan;Noga Givon-Lavi;Orly Zamir;Merav Sikuler-Cohen.
The Journal of Infectious Diseases (2002)
Comparison of human metapneumovirus, respiratory syncytial virus and influenza A virus lower respiratory tract infections in hospitalized young children.
Dana G Wolf;David Greenberg;Davina Kalkstein;Yonat Shemer-Avni.
Pediatric Infectious Disease Journal (2006)
Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population.
Ron Dagan;Noga Givon-Lavi;Eugene Leibovitz;David Greenberg.
The Journal of Infectious Diseases (2009)
Comparative Immunogenicity and Efficacy of 13-Valent and 7-Valent Pneumococcal Conjugate Vaccines in Reducing Nasopharyngeal Colonization: A Randomized Double-Blind Trial
Ron Dagan;Scott Patterson;Christine Juergens;David Greenberg.
Clinical Infectious Diseases (2013)
Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees.
Ron Dagan;Merav Sikuler-Cohen;Orly Zamir;Jacob Janco.
Pediatric Infectious Disease Journal (2001)
Serum Serotype-Specific Pneumococcal Anticapsular Immunoglobulin G Concentrations after Immunization with a 9-Valent Conjugate Pneumococcal Vaccine Correlate with Nasopharyngeal Acquisition of Pneumococcus
Ron Dagan;Noga Givon-Lavi;Drora Fraser;Marc Lipsitch.
The Journal of Infectious Diseases (2005)
Effect of a Nonavalent Conjugate Vaccine on Carriage of Antibiotic-Resistant Streptococcus Pneumoniae in Day-Care Centers
Ron Dagan;Noga Givon-Lavi;Orly Zamir;Drora Fraser.
Pediatric Infectious Disease Journal (2003)
Site-specific disease potential of individual Streptococcus pneumoniae serotypes in pediatric invasive disease, acute otitis media and acute conjunctivitis.
Dror S. Shouval;David Greenberg;Noga Givon-Lavi;Nurith Porat.
Pediatric Infectious Disease Journal (2006)
Near-elimination of otitis media caused by 13-valent pneumococcal conjugate vaccine (PCV) serotypes in southern Israel shortly after sequential introduction of 7-valent/13-valent PCV.
Shalom Ben-Shimol;Noga Givon-Lavi;Eugene Leibovitz;Simon Raiz.
Clinical Infectious Diseases (2014)
The contribution of smoking and exposure to tobacco smoke to Streptococcus pneumoniae and Haemophilus influenzae carriage in children and their mothers.
David Greenberg;Noga Givon-Lavi;Arnon Broides;Irena Blancovich.
Clinical Infectious Diseases (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: